This 2022 review comprehensively examines mammary microcalcifications (MCs), highlighting their significance as markers for breast cancer detection. The study categorizes MCs into three types based on composition: Type I (calcium oxalate), typically benign; Type II (hydroxyapatite), associated with both benign and malignant lesions; and magnesium-substituted hydroxyapatite (Mg-HA), predominantly linked to
